Publications by authors named "Chengyou Yu"

Claim this Profile
P
Predictive value of soluble PD-1 for HBsAg loss in HbeAg-negative patients with chronic hepatitis B: results from a prospective study.
Huili Guo, Lili Wu, Chengyou Yu, Huiying Yu, Wenjian Deng

Hepatol Int· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD45 erythroid progenitor cells as potential biomarkers for disease progression in hepatitis B virus-related acute-on-chronic liver failure.
Nan Zhang, Hai-Shi Wu, Xiu-Qing Pang, Cheng-You Yu, Xing Li

BMC Gastroenterol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ARH score, a practical guide to decision-making for retreatment with hepatic arterial infusion chemotherapy in hepatocellular carcinoma patients.
Jie Mei, Chengyou Yu, Feng Shi, Renguo Guan, Shaohua Li

Int Immunopharmacol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A preliminary study on drug switching strategy for second-line therapy after combination treatment of tyrosine kinase inhibitors and immune checkpoint inhibitors for unresectable hepatocellular carcinoma.
Renguo Guan, Chengyou Yu, Shaohua Li, Jie Mei, Wei Wei

Front Pharmacol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long noncoding RNA TINCR facilitates hepatocellular carcinoma progression and dampens chemosensitivity to oxaliplatin by regulating the miR-195-3p/ST6GAL1/NF-κB pathway.
Jie Mei, Wenping Lin, Shaohua Li, Yuhao Tang, Zhiwei Ye, Yuhua Wen, Chengyou Yu

J Exp Clin Cancer Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis